Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/1999
06/17/1999CA2309026A1 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones
06/16/1999EP0922705A1 Fluorinated Cephalosporin antibiotics for treatment of mastitis
06/16/1999EP0922455A1 Hiv-1 protease inhibitors, process for producing the same, and medicinal compositions
06/16/1999EP0922092A1 Method of attenuating viruses
06/16/1999EP0922059A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
06/16/1999EP0922044A1 Pyrrolo(3,2-c) quinoline derivatives
06/16/1999EP0922030A1 Arylsulfonylamino hydroxamic acid derivatives
06/16/1999EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
06/16/1999EP0921811A2 Administration of histamine for therapeutic purposes
06/16/1999EP0921803A1 Methods for preventing and treating pestivirus infection and associated diseases
06/16/1999EP0921801A1 Inhibitors of farnesyl-protein transferase
06/16/1999EP0921791A1 Composition comprising mupirocin and chlorhexidine
06/16/1999EP0827507B1 Protease inhibiting succinic acid derivatives
06/16/1999EP0757690A4 Electron-deficient porphyrins and processes and intermediates for preparing same
06/16/1999EP0640128B1 Attenuated respiratory syncytial virus vaccine compositions
06/16/1999CN1219969A Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same
06/16/1999CN1219929A Urea derivatives as inhibitors of IMPDH enzyme
06/16/1999CN1219928A Novel vitamin D analogues
06/16/1999CN1219927A Phenylalkylcarboxylic acid derivatives
06/16/1999CN1219881A Caprine arthritis-encephalitis virus provides immunoprotection against HIV-1 infection
06/16/1999CN1219872A Compositions and method for treating or preventing diseases of body passageways
06/16/1999CN1219538A Antifungal agent and its preparing process and intermediate
06/15/1999US5912372 Water-miscible esters of monoglycerides having antimicrobial activity
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease
06/15/1999US5912331 Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
06/15/1999US5912257 Two-photon upconverting dyes and applications
06/15/1999US5912228 Mixture with ethylene oxide-propylene oxide block copolymer and ethylenediaminetetraacetic acid
06/15/1999US5912176 Antibodies against a host cell antigen complex for pre and post exposure protection from infection by HIV
06/15/1999US5911999 Vaccine based on TGEV for protection of dogs against canine coronavirus
06/15/1999US5911998 Inoculating cultures(which are free of adventitious microbial agents) with desired virus, then incubation and harvesting virus for use in vaccine
06/15/1999US5911996 Fusion proteins from actinobacillus, soluble on sodium lauryl sarcosinate derived by genetic engineering for immunity
06/15/1999US5911990 Restoring normal immune response by administering peptide which stimulates production of interferon-gamma and interleukin-5 while suppressing production of immunoglobulin-g and interleukins-5,-6 and-10
06/15/1999US5911989 Antibodies
06/15/1999US5911987 Cell surface protein and effector cell bonding reagent
06/15/1999US5911985 Pharmaceutical formulations containing a β-lactamase inhibiting penem in combination with β-lactam antibiotic and their use in the treatment of bacterial infections
06/15/1999CA2014465C Herpesvirus recombinant poxvirus vaccine
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028492A1 A method of finding agonist and antagonist to human 11cb splice variant
06/10/1999WO1999028478A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines
06/10/1999WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/10/1999WO1999028338A1 Inhibition of nuclear import by backbone cyclic peptide analogs
06/10/1999WO1999028333A1 Chemical synthesis of 6-o-alkyl erythromycin c
06/10/1999WO1999028332A1 6-o-alkyl erythromycin b oxime
06/10/1999WO1999028322A1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
06/10/1999WO1999028317A1 Substituted phenyloxazolidinones and their use as antibiotics
06/10/1999WO1999028311A1 6-o-alkyl derivatives of erythronolide b
06/10/1999WO1999027964A1 Multivalent recombinant antibodies for treating hrv infections
06/10/1999WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999WO1999027961A1 Transdermal delivery of particulate vaccine compositions
06/10/1999WO1999027960A1 Vaccine compositions for mucosal administration comprising chitosan
06/10/1999WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999WO1999027955A2 Treatment of established chronic infections and cancers
06/10/1999WO1999027952A1 Anti-hypoxic and anti-ischemic drug
06/10/1999WO1999027945A1 Threonine-containing protegrins
06/10/1999WO1999027931A1 USE OF BICOZAMYCIN FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING INFECTIONS WITH ENTEROHEMORRHAGIC $i(E. COLI)
06/10/1999WO1999027927A1 Synergistic antimicrobial compositions
06/10/1999WO1999027922A1 The use of polyols in combating yeast infection and polyol preparations for said use
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1999027793A2 An antimicrobial composition
06/10/1999WO1999015535A8 Binuclear complex
06/10/1999WO1999015013A3 Use of quaternary carboxylic acid alkanolamine ester salts as microbicidal agents
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999010375A3 Vaccine against hpv
06/10/1999DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders
06/10/1999CA2313028A1 Multivalent recombinant antibodies for treating hrv infections
06/10/1999CA2312900A1 Transdermal delivery of particulate vaccine compositions
06/10/1999CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999CA2312811A1 Synergistic antimicrobial compositions
06/10/1999CA2312191A1 Threonine-containing protegrins
06/10/1999CA2311798A1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
06/10/1999CA2311768A1 Inhibition of nuclear import by backbone cyclic peptide analogs
06/10/1999CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999CA2310718A1 Vaccine compositions for mucosal administration comprising chitosan
06/10/1999CA2310003A1 Chemical synthesis of 6-o-alkyl erythromycin c
06/10/1999CA2309977A1 6-o-alkyl derivatives of erythronolide b
06/10/1999CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/09/1999EP0921121A1 Intermediates to therapeutic nucleosides
06/09/1999EP0921114A1 Intermediates to therapeutic nucleosides
06/09/1999EP0920867A1 Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
06/09/1999EP0920865A1 Pharmaceutical compositions containing Norastemizole
06/09/1999EP0920530A1 Screening methods using microbial strain pools
06/09/1999EP0920527A1 SYNTHESIS OF beta-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE
06/09/1999EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
06/09/1999EP0920507A2 Secreted proteins and polynucleotides encoding them
06/09/1999EP0920421A1 Isoxazoline derivatives useful as antimicrobials
06/09/1999EP0920419A1 Compounds, compositions and methods for treating influenza
06/09/1999EP0920331A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
06/09/1999EP0920324A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
06/09/1999EP0920262A1 Nutritional formulations containing water-miscible lipid derivatives as antimicrobial agents
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999EP0730598B1 Hindered esters of rapamycin and their use as pharmaceuticals
06/09/1999CN1219174A Inhibitors of protein farnesyl transferase
06/09/1999CN1219124A Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of skin and textile fibre materials
06/09/1999CN1219103A Antibiotic cocktail and method of use
06/09/1999CN1218833A Polypeptide with cell withering promoting activity
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/09/1999CN1218666A Nef function inhibitor
06/08/1999US5910508 Novel compounds useful in modulating cellular hormone receptors; treating skin disorders such as acne, psoriasis
06/08/1999US5910506 Imidazole derivatives as anti-HIV agents
1 ... 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 ... 1798